Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
The JBS Australia study documented the carbon footprints of 176 cattle farms that claimed to be implementing regenerative agriculture practices.
Eleven states have confirmed cases of High-Path Avian Flu (HPAI H5N1) in dairy herds, with the latest confirmed outbreak coming out of Minnesota.
With ransomware and other cybersecurity threats on the rise, the U.S. Small Business Association wants to help bolster the resources available to farmers and other rural Americans who operate small businesses.
